Deferoxamide B en es it fr

Deferoxamide B Brand names, Deferoxamide B Analogs

Deferoxamide B Brand Names Mixture

  • No information avaliable

Deferoxamide B Chemical_Formula

C20H29N3O2

Deferoxamide B RX_link

No information avaliable

Deferoxamide B fda sheet

Deferoxamide B msds (material safety sheet)

Deferoxamide_B MSDS

Deferoxamide B Synthesis Reference

No information avaliable

Deferoxamide B Molecular Weight

343.463 g/mol

Deferoxamide B Melting Point

99-101oC (HCl salt)

Deferoxamide B H2O Solubility

42 mg/L

Deferoxamide B State

Solid

Deferoxamide B LogP

3.588

Deferoxamide B Dosage Forms

Ointment

Deferoxamide B Indication

For production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks.

Deferoxamide B Pharmacology

Dibucaine is an amide-type local anesthetic, similar to lidocaine.

Deferoxamide B Absorption

In general, ionized forms (salts) of local anesthetics are not readily absorbed through intact skin. However, both nonionized (bases) and ionized forms of local anesthetics are readily absorbed through traumatized or abraded skin into the systemic circulation.

Deferoxamide B side effects and Toxicity

Subcutaneous LD50 in rat is 27 mg/kg. Symptoms of overdose include convulsions, hypoxia, acidosis, bradycardia, arrhythmias and cardiac arrest.

Deferoxamide B Patient Information

No information avaliable

Deferoxamide B Organisms Affected

Humans and other mammals